Moonshot AI Funding Round Doubles to $3.5B at $35B Valuation
The Moonshot AI funding round raised $3.5 billion and set the Beijing lab's post-money valuation at $35 billion, according to Bloomberg. Moonshot had originally targeted $1 billion to $2 billion. The Series F closed this week, two weeks after the Kimi K3 release turned the company from a Chinese AI unicorn into a global frontier contender.
Annual recurring revenue stood at $100 million in March and $300 million in June. Moonshot has begun lining up investors for a follow-on round at a $50 billion pre-money valuation. The company expects that to be its last privately negotiated financing before a Hong Kong IPO, which it hopes to hold before the end of 2026. The just-closed round is the first leg of that two-stage fundraising we previously reported.
Kimi K3 is the asset the market is pricing. Launched July 16, the model runs 2.8 trillion parameters with 104 billion active during inference and a one-million-token context window, and Moonshot published the full weights on July 27. That makes K3 the largest open-weight model available. Moonshot says its coding and knowledge-work results are at the frontier, comparable to Anthropic's Claude Fable 5 and OpenAI's GPT-5.6 Sol. The one-million-token window targets the long-document and codebase workloads the closed vendors are also chasing. The release unsettled the US industry, and the commercial effect showed up within days: daily sales rose sixfold, which explains how ARR tripled in a single quarter.
Moonshot was founded about three years ago, and its valuation has climbed from roughly $300 million to $35 billion. The pace of that move is the notable part: about $4.8 billion in January to $35 billion now is a jump of more than seven times in seven months, with the single K3 release as the only intervening product event. Investors are paying for evidence that frontier capability can be produced under constraints; product diversification is not the draw.
The sixfold jump in daily sales is the operational side of the valuation story: paid usage produced revenue within days of launch, giving Moonshot a real revenue base to show investors instead of a roadmap. Publishing weights on July 27, eleven days after launch, shortens the window for independent testing of performance claims. It also commits the lab to competing on serving infrastructure and cost, not on access to the model itself.
| Milestone (2026) | Figure |
|---|---|
| January valuation | ~$4.8 billion |
| March ARR | $100 million |
| June ARR | $300 million |
| Kimi K3 launch (July 16) | 2.8T params, 1M-token context |
| Weights published (July 27) | Open-weight release |
| Closed round (July 29) | $3.5B at $35B post-money |
| Follow-on pre-money | $50 billion |
Who wrote the checks
The lead investors include the National Artificial Intelligence Industry Investment Fund, a state vehicle that also backs DeepSeek. Beijing now holds a direct capital stake in both of China's leading open-weight labs, and the round closed five days after the US Treasury threatened sanctions on the company, a geopolitical risk the market appears to have priced at zero.
Raising more than double a target that was itself set in the billions is unusual. Rounds that overshoot this far usually reflect investors competing for allocation, and the signal here is that the market wanted exposure to the open-weight thesis before the IPO window closes. Moonshot is now offering the next round at a $50 billion pre-money valuation.
Moonshot says the proceeds will go to compute capacity and successor models, which is where the constraint actually sits. The policy environment is part of the picture: Anthropic's chief executive has argued for restricting advanced chip flows to China and for safety testing of frontier models, and Moonshot itself points to compute as its binding constraint. A lab training at this scale needs capital mainly to secure compute access and fund the next run, a different use of funds than the product-side spending that dominates most US AI startups.
Moonshot AI funding round: the capital-efficiency test
A $35 billion valuation on roughly $300 million of recurring revenue implies a multiple near 117x, arithmetic that would be hard to defend for a closed-model vendor at the same stage. The multiple looks less extreme in context: AI venture rounds are priced on growth and scarcity of allocation, and Moonshot's revenue tripled in the quarter the round was negotiated. The open question is what happens when a public market applies its own discounting after the listing.
What investors are underwriting is open-weight economics: publishing weights removes the per-token API toll booth the US frontier labs depend on for revenue, and it shifts the competitive question from who can train the biggest model to who can deliver frontier capability at the lowest cost. For enterprises, the payoff is local deployment and customization without vendor lock-in, which is the option the closed labs do not offer.
The Moonshot AI funding round is therefore a direct challenge to the closed-lab model. Moonshot reached the frontier table with a capital base far smaller than what OpenAI and Anthropic have consumed, and it did so with weights anyone can download. The trade-off follows from that strategy: open weights also mean competitors can build on K3, so the moat has to come from training cost and data rather than distribution. The unresolved question is monetization depth, since the lab gives up the API toll booth that funds US rivals' next training runs; the $300 million ARR figure is the early evidence that revenue can still be collected some other way.
What the $50 billion follow-on tests
Investors who missed the Moonshot AI funding round get a second chance in the follow-on, marketed at a $50 billion pre-money valuation. The gap between a $35 billion post-money close and a $50 billion pre-money ask is itself a signal: it suggests the market believes the last round was not the ceiling, and that momentum is doing part of the pricing work.
Two things will be tested in the next round. The first is demand beyond state capital: a raise of that size needs global institutional participation alongside the domestic vehicles that anchored the $3.5 billion raise. The second is whether the ARR curve can keep pace with the multiple: tripling revenue in three months justified the move from $4.8 billion to $35 billion, and the follow-on assumes that growth continues through the Hong Kong listing.
For late-stage investors, the trade-off is the strongest open-weight position in the market against a revenue base still small relative to the valuation. For enterprise buyers, the calculation is more direct: a frontier model that can run in-house, on private infrastructure, without per-token fees is a procurement option the closed US vendors now have to match on price. An open-weight frontier model puts a ceiling on what any vendor can charge per token, which is the pressure the policy pushback against Moonshot signals in return.
The strategic position is unusual. Moonshot holds the largest open-weight model on the market, a state-backed capital base, and a fast-growing revenue line, but it faces hardware constraints US rivals do not, because export policy limits its access to advanced chips. Each of those facts pulls the valuation in a different direction, which is why the next two events, the $50 billion round and the Hong Kong listing, will matter more than the $35 billion mark itself.
Why this matters
The Moonshot AI funding round is a working example of capital-efficient frontier AI: a lab that reached a $35 billion valuation on $300 million of ARR, state-anchored capital, and publishable weights. If the $50 billion pre-money follow-on and the Hong Kong listing clear, the open-weight path becomes a durable third option alongside the closed labs; if the revenue multiple does not hold in public markets, it becomes the first serious stress test of that arithmetic. Either way, the pricing pressure the model puts on US labs' API revenue is already set in motion.
Related Articles
- Moonshot AI Pre-IPO Valuation Hits $50B Target in Back-to-Back Fundraising Before Hong Kong Listing
- Chinese Startup Moonshot AI Seeks $30 Billion Valuation in Latest Funding Round
- Kimi K3 valuation impact: $314B cut from AI pre-IPO estimates
✔Human Verified
Researched and cross-referenced against primary sources by the Bytevyte editorial team. This article was generated with the assistance of artificial intelligence and reviewed by the Bytevyte editorial team.